APA
Gorry P., National Bureau of Economic Research & Useche D. (2017). Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies. Cambridge: NBER.
Chicago
Gorry Philippe, National Bureau of Economic Research and Useche Diego. 2017. Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies. Cambridge: NBER.
Harvard
Gorry P., National Bureau of Economic Research and Useche D. (2017). Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies. Cambridge: NBER.
MLA
Gorry Philippe, National Bureau of Economic Research and Useche Diego. Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies. Cambridge: NBER. 2017.
TextSeries: NBER Working Paper ; 24021Publication details: Cambridge NBER 2017Description: 29pSubject(s): Online resources:
Working Papers (Electronic)
